Financial Disclosures on Drug Studies Found Lacking, Health and Human Services Department’s Head Announces

Jan. 12 (Bloomberg) -- Drug regulators haven’t done enough to force disclosure of financial conflicts of interest among the researchers who conduct clinical trials of medications and medical devices, according to a U.S. government investigation.